Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Bevacizumab and platinum-based combinations for recurrent ovarian cancer: a randomised, open-label, phase 3 trial

PaperCitations, authors & open-access status

Bevacizumab and platinum-based combinations for recurrent ovarian cancer: a randomised, open-label, phase 3 trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 163 citations, 2020 year and green oa status.

163
Citations
2020
Year
green
OA Status

Related on ScholarIQ

Sven� Mahner
Author
The Lancet Oncology
Journal
Ovarian cancer diagnosis and treatment
Topic
Ovarian cancer diagnosis and treatment
Topic
PARP inhibition in cancer therapy
Topic
Protease and Inhibitor Mechanisms
Topic
470M+ articles · free account